Dossier Submission
AI for Dossier Preparation

AI for Dossier Preparation: Faster DMF & Drug Product Submissions with CMC Automation

In pharmaceutical development, regulatory documentation is not simply an administrative task. It is a critical step that directly impacts approval timelines.  When you are responsible for preparing DMF (Drug Master File) and drug product submissions, every section must be scientifically accurate, internally consistent, and aligned with regulatory expectations. Preparing a complete dossier often takes several months and, in many cases, close […]

Dossier Submission

2026 Renewal Submissions Explained: A Practical Guide for Regulatory Teams

If you’re responsible for regulatory renewals, 2026 is not business as usual.  Health authorities across the globe are no longer just accepting electronic submissions — they are actively enforcing precision, structure, and lifecycle discipline. When your product licence is on the line, renewal submissions must be more than complete; they must be technically flawless, audit-ready, and digitally optimised from day one.  Regulators such as the U.S. FDA, […]

Dossier Submission
How to Successfully Update Your Dossier A Guide to Post-Approval Variations

How to Successfully Update Your Dossier: A Guide to Post-Approval Variations

How to Successfully Update Your Dossier: A Guide to Post-Approval Variations  So, you’ve got the Marketing Authorisation (MA) for your medicinal product! But, let’s be real, it’s not a one-and-done deal. As your product’s lifecycle progresses, you’ll need to make updates to its dossier to ensure it remains compliant with regulatory requirements.  What’s a Variation, Anyway?   A variation is any change to a medicinal product’s registered dossier, decision granting MA, Summary of Product Characteristics, Package Leaflet, […]

eCTD submission

Why Some Countries Still Accept NeeS—And What That Means for Your Submission Strategy

As the pharmaceutical industry increasingly adopts the electronic Common Technical Document (eCTD) as a global submission standard, Non-eCTD electronic Submissions (NeeS) continue to hold relevance in certain regions. Regulatory affairs professionals managing multi-region dossiers must understand where NeeS remains accepted, what limitations it presents, and how to plan an adaptable submission strategy accordingly.  This blog explores why NeeS still exists, which markets continue to support […]

eCTD submission

Global Regulatory Authorities Requiring CTD/eCTD: Why It’s Time to Standardize Your Submission Process

In today’s global pharmaceutical landscape, regulatory submissions must meet highly structured standards—and those standards are rapidly evolving. As more countries transition from paper-based Common Technical Documents (CTD) to fully digital electronic CTD (eCTD) formats, companies are under increasing pressure to stay compliant across all regions.  Understanding which authorities require or accept CTD or eCTD is […]

eCTD submission

How an eCTD Software Solution Simplifies Regulatory Submissions

How an eCTD Software Solution Simplifies Regulatory Submissions  Pharmaceutical regulatory submissions have evolved from paper-based chaos to highly structured electronic formats. The electronic Common Technical Document (eCTD) has become the global standard for submitting dossiers to agencies like the USFDA, EMA, Health Canada, PMDA, and others.  But with stringent formatting rules, metadata tagging, version control, […]

Dossier Submission

Differences in Dossier Submission Requirements: USFDA, Health Canada, EMA, and More

Pharmaceutical companies planning to market their products internationally must navigate a complex web of regulatory submission requirements. While many regions follow the ICH Common Technical Document (CTD) or its electronic version (eCTD), each regulatory authority has its own specifications, processes, and expectations.  Understanding these differences is essential for regulatory affairs professionals to avoid delays, technical […]

eCTD submission

Understanding MHRA’s eCTD Guidance for International Recognition Procedure (IRP)

With Brexit transforming the regulatory landscape in the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) has taken strategic steps to streamline drug approvals. One of the key post-Brexit regulatory pathways is the International Recognition Procedure (IRP), which allows faster approval of medicines already authorized by trusted reference regulators.  To support this procedure, the […]

eCTD submission

Support isn’t a backup plan — It’s your fast track to eCTD submission success

In regulatory affairs, eCTD submissions aren’t just about compiling documents and hitting “send.” They’re about precision, timing, and compliance — and when something goes wrong (because it often does), the strength of your support system determines whether you succeed or scramble to recover.  Let’s dive into why support isn’t optional — it’s essential — and […]

eCTD submission
eCTD Dossier Submission

The 4 Pillars of eCTD Dossier Submission Success: Simplification, Cost, Usability, and Support

When it comes to eCTD dossier submissions, success isn’t just about getting approvals — it’s about getting them approved faster, smoother, and without errors. To achieve that, four pillars are essential: simplified submissions, cost-effectiveness, user-friendliness, and global support. Let’s break down why these four factors are the ultimate formula for success — and how KnowledgeNET […]

Book a Demo